Monographie - Epirubicin hydrochloride

Poslední aktualizace :
19/11/2024

Epirubicin hydrochloride

Cheminė sandara

Prekinis pavadinimas

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Anthracine	Malaizija
Axirubicine	Vokietija
Bendaepi	Vokietija
Binarin	Meksikas
Bioepycina	Lenkija
Crisabon	Argentina
Cuatroepi	Argentina
Ecclepia	Rumunija
Elebicin	Meksikas
Ellence	Jungtinės Amerikos Valstijos
Epi Cell	Vokietija
Epidoxo	Argentina, Čilė, Venesuela
Epifil	Ekvadoras
Epilem	Kolumbija, Meksikas
Epimedac	Vokietija
Epirubicin	Australija, Austrija, Belgija, Danija, Didžioji Britanija, Islandija, Naujojoje Zelandijoje, Saudo Arabija, Švedija, Šveicarija, Turkija, Vengrija
Epirubicina	Argentina, Ekvadoras, Ispanija, Kolumbija, Meksikas, Rumunija
Epirubicine	Belgija, Prancūzija, Šveicarija
Farmarubicin	Turkija
Farmorubicin	Austrija, Brazilija, Danija, Graikija, Norvegija, Saudo Arabija, Suomija, Švedija, Šveicarija
Farmorubicin CSV	Pietų Afrikos Respublika
Farmorubicin PFS	Kroatija, Lenkija, Slovėnija
Farmorubicin RD	Brazilija, Lenkija, rusų, Šveicarija
Farmorubicin RTU	Olandija
Farmorubicina	Brazilija, Ispanija, Italija, Portugalija
Farmorubicine	Belgija, Prancūzija
Pharmorubicin	Didžioji Britanija

Bibliografija : Epirubicin hydrochloride

	tipas	leidinys
148	Žurnalas	Dine T, Cazin JC, Gressier B, Luycks M, Brunet C, Cazin M, Goudaliez F, Mallevais ML, Toraub I. Stability and compatibility of four anthracyclines: doxorubicin, epirubicin, daunorubicin and pirarubicin with PVC infusion bags. Pharm Weekbl [Sci] 1992 ; 14: 365-369.
525	Žurnalas	De Vroe C, De Muynck C, Remon JP, Samsom M. A study on the stability of three antineoplastic drugs and on their sorption by IV delivery systems and end-line filters. Int J Pharm 1990 ; 65: 49-56.
683	Žurnalas	Walker SE, Lau DWC, DeAngelis C, Iazetta J, Coons C. Epirubicin stability in syringes and glass vials and evaluation of chemical contamination. Can J Hosp Pharm 1990 ; 43: 265-272.
686	Žurnalas	Wood MJ, Irwin WJ, Scott DK. Stability of doxorubicin, daunorubicin and epirubicin in plastic syringes and minibags. J Clin Pharm Ther 1990 ; 15: 279-289.
887	Žurnalas	Pujol M, Munoz M, Prat J, Giona V, De Bolos J. Stability study of epirubicin in NaCl 0.9% injection. Ann Pharmacotherapy 1997 ; 31: 992-995.
1237	Žurnalas	Keusters L, Stolk LML, Umans R, Van Asten P. Stability of solutions of doxorubicin and epirubicin in plastic minibags for intravesical use after storage at -20°C and thawing by microwave radiation. Pharm Weekbl [Sci] 1986 ; 8: 194-197.
1265	Žurnalas	Wood MJ, Irwin WJ, Scott DK. Photodegradation of doxorubicin, daunorubicin and epirubicin measured by high-performance liquid chromatography. J Clin Pharm Ther 1990 ; 15: 291-300.
1317	Žurnalas	Adams PS, Haines-Hutt RF, Bradford E, Palmer A, Rowland CG. Pharmaceutical aspects of home infusion therapy for cancer patients. Pharm J 1987 ; 238: 476-478.
1662	Žurnalas	Trissel LA, Saenz CA, Ingram DS, Ogundele AB. Compatibility screening of oxaliplatin during simulated Y-site administration with other drugs. J Oncol Pharm Practice 2002 ; 8: 33-37.
1823	Žurnalas	Sewell GJ, Rigby-Jones AE, Priston MJ. Stability of intravesical epirubicin infusion: a sequential temperature study. J Clin Pharm Ther 2003 ; 28: 349-353.
1897	Žurnalas	Sautou-Miranda V, Brigas F, Thibault M, Chopineau J. Compatibility of doxorubicin, daunorubicin and epirubicin with low-density polyethylene and polyvinyl chloride, and stability in various conditions of storage. EJHP 2001 ; 7, 3: 108-115.
1955	Žurnalas	Trissel LA, Zhang Y. Palonosetron HCl compatibility and stability with doxorubicin HCl and epirubicin HCl during simulated Y-site administration. Ann Pharmacotherapy 2005 ; 39: 280-283.
2168	Žurnalas	Ozdemir FA, Anilanmert B, Pekin M. Spectrophotometric investigation of the chemical compatibility of the anticancer irinotecan-HCl and epirubicin-HCl in the same infusion solution. Cancer Chemother Pharmacol 2005 ; 56, 5: 529-534.
2257	Laboratorija	Stability of epirubicin "Ebewe" infusion solutions. Ebewe Pharma 2007
3473	Žurnalas	Bennis Y, Savry A, Correard F, Montana M, Sauzet C, Gauthier-Villano L, Pisano P, Pourroy B. Stability of a highly concentrated solution of epirubicin for conventional transcatheter arterial chemoembolization. Int J Pharm 2015 ; 495, 2: 956-962.
3474	Laboratorija	Fluorouracil - Summary of Product Characteristics Accord Healthcare Limited 2009
3632	Laboratorija	Epirubicine (Epirubicine Hospira®) - Summary of Product Characteristics Hospira 2017
3670	Žurnalas	Sewell G, Massimini M. Studies on the stability and compatibility of cytotoxic drug infusion with the Tevadaptor system. EJOP 2014 ; 8, 3: 26-30.
3708	plakatas	Sarakbi I, Thiesen J, Krämer I. Compatibility of epirubicin-loaded DC Beads with different contrast media. ECOP 2 Krakow 2014
3918	Žurnalas	Sarakbi I, Krämer I. Compatibility of epirubicin-loaded DC bead™ with different non-ionic contrast media. J Oncol Pharm Practice 2016 ; 22: 749-756.
4352	Žurnalas	Li J, Yao C, Xu Y, Ping P, Yin H, Sun Y. In vitro compatibility and stability of admixtures containing etoposide, epirubicin hydrochloride and vindesine sulphate in a single infusion bag. J Clin Pharm Ther 2019 ; 44: 875-882.

Mentions Légales